Table 2.
Quality and Bias Assessment of included trials
| Mittal et al. 2011 | Abid et al. 2011 | Alvares-da-Silva et al. 2014 | Varakanahalli et al. 2018 | Higuera-de la Tijera et al. 2018 | Bai et al. 2014 | |
|---|---|---|---|---|---|---|
| A. Jadad Score | ||||||
| Randomization | 2 | 1 | 2 | 2 | 2 | 2 |
| Blinding | 0 | 1 | 1 | 2 | 2 | 2 |
| Dropouts | 1 | 1 | 1 | 1 | 1 | 1 |
| Total score | 3 | 3 | 4 | 5 | 5 | 5 |
| B. Cochrane Score | ||||||
| Selection bias (randomization) | L | L | L | L | L | L |
| Selection bias (blinding) | L | L | L | L | L | L |
| Performance Bias | H | L | L | L | L | L |
| Detection bias | H | UC | L | L | L | L |
| Reporting bias | L | L | L | L | L | L |
| Overall bias | UC | L | L | L | L | L |
Trial quality is indicated by a score of 1–5 on the Jadad scale; scores of 3 or above indicate high quality. Assessment of risk of bias due to randomization, blinding, detection and attrition using the Cochrane tool for risk of bias assessment as described in Methods. L low, H high, UC unclear